Covid-19 Study, Diagnostic and Therapeutic Transition

Area of Science:

• Virology
• Epidemiology
• Public Health

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, emerged three years ago, revealing significant global disparities in healthcare responses and legislation.
• Despite initial challenges, social and healthcare systems worldwide have adapted, formalizing diagnostic and therapeutic protocols.

Purpose of the Study:

• To analyze the evolution of COVID-19 diagnosis and therapeutics globally over the past three years.
• To highlight the need for continued research into SARS-CoV-2 biology and the development of novel countermeasures.
• To establish a framework for diagnostic and therapeutic transitions considering diverse socioeconomic conditions and policies.

Main Methods:

• Review of formalized diagnostic and therapeutic strategies, including vaccines and drug regimens.
• Investigation into the viral origins, biology, and strain-specific drug targeting of SARS-CoV-2.
• Analysis of the role of animal models and pathophysiological knowledge in understanding COVID-19.

Main Results:

• Diagnostic advancements and therapeutic selections worldwide have improved patient outcomes and curability.
• Understanding viral spread and mortality, alongside existing knowledge, has been vital in managing the pandemic.
• The emergence of COVID-19 variants necessitated adaptive therapeutic strategies.

Conclusions:

• Diverse diagnostic platforms offer varied therapeutic options, influencing patient response and clinical benefits.
• Advanced diagnostic dimensions and therapeutic paradigms are essential for optimizing COVID-19 patient recovery.
• Continuous updates in biomedical knowledge, vaccines, and therapeutic strategies are imperative for global health security.